Indiaâs drug regulator gives nod for worldâs first nasal Covid-19 vaccine
Indiaâs drug regulator, the Central Drugs Standard Control Organisation, has given its nod for the restricted use of the worldâs first intra-nasal vaccine.
Bharti Rana Jayshankar – Founder
She brings in more than 30 years of experience in content building, architecture, writing, editing and storytelling. Ms Jayshankar has worked in the Economic Times daily, IBT Times, Investopedia and more than a dozen content firms as a content strategist and planner.
Jay Shankar – Co-founder
He has almost three decades of experience in journalism. He has worked with national dailies such as ET, Indian Express, The Pioneer, The Hindu, Agence France Presse and Bloomberg.
Indiaâs drug regulator, the Central Drugs Standard Control Organisation, has given its nod for the restricted use of the worldâs first intra-nasal vaccine.
Alembic Pharmaceuticals, an Indian maker of generic drugs, has received FDA approval for diclofenac medicine used to treat osteoarthritis of the knees.
AstraZeneca, an Anglo-Swedish pharmaceutical company, is set to acquire Neogene Therapeutics, a biotechnology firm, for $320 million
The FDA is probing a drug, Prolia, used for the treatment of advanced kidney disease after initial investigations showed âa substantial risk with.
Baxter International has pulled the plug on its hospital bed systems in a recall termed by the FDA as âmost seriousâ as the.
Biovac, a South Africa-based biotechnology company, has signed a technology transfer agreement with a South Korean institute to make an oral cholera vaccine.
Merck, a US multinational pharmaceutical company, announced it would acquire Imago BioSciences for $1.35 billion.
Swedish researchers have found a potential biomarker for severe Covid-19 disease that has claimed the lives of more than 6.5 million people globally.
WHO drafts an agreement for pharma companies to disclose contract terms for emergency vaccines
Antimalarial drug resistance in Africa is a severe cause for concern and parasite resistance to artemisinin medicine has emerged in the Greater Mekong.
We use cookies to improve your experience on our site. By using our site, you consent to cookies.
Manage your cookie preferences below:
Essential cookies enable basic functions and are necessary for the proper function of the website.
Statistics cookies collect information anonymously. This information helps us understand how visitors use our website.
Google Analytics is a powerful tool that tracks and analyzes website traffic for informed marketing decisions.
Service URL: policies.google.com